Add time:09/10/2019 Source:sciencedirect.com
IntroductionThe redox characteristics of 1,2,4-benzotriazine-1,4-dioxides (BTDOs) make them potential radiosensitizing agents for hypoxic cells in solid human cancers. Tirapazamine (TPZ) is the most clinically tested BTDO radiosensitizer, despite its toxicity at effective doses. To date, no BTDOs have been developed as diagnostic markers of tissue hypoxia.
We also recommend Trading Suppliers and Manufacturers of 3-AMINO-7-CHLORO-1,2,4-BENZOTRIAZINE-1-OXIDE (cas 18671-92-6). Pls Click Website Link as below: cas 18671-92-6 suppliers
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View